About Subhasree Kar
Subhasree’s keen interest in financial instruments led her to pursue a career as an investment analyst. After earning a Master’s degree in Economics, she gained knowledge of equity research and portfolio management at Finlatics.
She uses her knowledge as a fundamental analyst to help investors make informed decisions in regards to their investment portfolios.
Recent Articles By Subhasree Kar
Coinbase (COIN) 2024 Crypto Breakdown: Buy Signals Ahead?
Coinbase (COIN) is locked in multiple legal battles with the U.S. Securities and Exchange Commission (SEC). However, is it a buy, as cryptocurrencies staged a recovery? Read on...
Tesla (TSLA) Stock Outlook: Will it Ride the Tech Wave in 2024?
Electric vehicle giant Tesla (TSLA) seems to be losing market share amid an increasingly competitive landscape. So, will it be worth buying the stock for gains? Let’s discuss...
Should You Buy, Hold, or Sell CalAmp (CAMP) Stock?
Telematics solution provider CalAmp (CAMP) expects its fiscal third quarter revenues and Adjusted EBITDA to be down sequentially. With the company gearing up to release its quarterly results, is the stock a Buy, Hold or Sell now? Keep reading...
Analyzing the Year-End Rise of AT&T (T) -- Buy or Hold?
AT&T (T) is currently struggling with its debt burden and slowing wireless subscriber growth. While T is registering year-end gains, is the stock worth buying? Read on...
T-Mobile (TMUS) December Surge: Buy or Hold?
T-Mobile (TMUS) is fast growing in the 5G space with expanding network coverage and capacity. With the stock soaring over the past month, is it the right telecom pick now? Read on...
Auto Stock Trio: Buy, Hold, or Sell in 2024?
The global automotive industry is on a strong stride amid steady demand and innovation. So, let us analyze whether to Buy, Hold, or Sell auto stocks - Mazda Motor (MZDAY), Ford Motor (F) and Fisker (FSR). Read on...
NFLX's Year-End Performance: Buy or Hold?
Streaming giant Netflix (NFLX) shares witnessed an impressive run this year amid robust subscriber growth and margin expansion. However, will the momentum be sustained into 2024? Let’s discuss...
Analyzing the Year-End Performance of Starbucks (SBUX)
Starbucks (SBUX) has been in a tough spot over the past few weeks amid boycotts over the Israel-Hamas war and foot traffic declines. So, could the world's largest coffee company stock still be a worthy year-end buy? Read on...
3 Pharma Stock Buys for Last-Minute Year-End Profits
Growing healthcare spending and the use of cutting-edge technologies in the research and development of new drugs have put the pharmaceutical industry in a strong position for growth. With such constructive trends in mind, it's wise to buy fundamentally strong pharma stocks, Merck (MRK), Collegium (COLL) and Johnson & Johnson (JNJ) for year-end profits. Read on...